• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antigenic Change in Human Influenza A(H2N2) Viruses Detected by Using Human Plasma from Aged and Younger Adult Individuals

tetano

Editor, Senior Moderator
Viruses. 2019 Oct 23;11(11). pii: E978. doi: 10.3390/v11110978. [h=1]Antigenic Change in Human Influenza A(H2N2) Viruses Detected by Using Human Plasma from Aged and Younger Adult Individuals.[/h]
Matsuzawa Y[SUP]1[/SUP], Iwatsuki-Horimoto K[SUP]2[/SUP], Nishimoto Y[SUP]3[/SUP], Abe Y[SUP]4[/SUP], Fukuyama S[SUP]5[/SUP], Hamabata T[SUP]6[/SUP], Okuda M[SUP]7[/SUP], Go Y[SUP]8[/SUP], Watanabe T[SUP]9[/SUP], Imai M[SUP]10[/SUP], Arai Y[SUP]11[/SUP], Fouchier RAM[SUP]12[/SUP], Yamayoshi S[SUP]13[/SUP], Kawaoka Y[SUP]14,[/SUP][SUP]15,[/SUP][SUP]16[/SUP].
[h=3]Author information[/h] 1 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. ymatsuza@ims.u-tokyo.ac.jp. 2 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. kenken@ims.u-tokyo.ac.jp. 3 Center for Supercentenarian Medical Research, Shinjuku-ku, Tokyo 160-8582, Japan. ynishimo@z3.keio.jp. 4 Center for Supercentenarian Medical Research, Shinjuku-ku, Tokyo 160-8582, Japan. yukiko_abe@keio.jp. 5 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. fukuyamarry@gmail.com. 6 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. hamabata@ims.u-tokyo.ac.jp. 7 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. kk176356@stu-cbms.k.u-tokyo.ac.jp. 8 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. yuigo555@gmail.com. 9 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. tokiko.watanabe@wisc.edu. 10 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. mimai@ims.u-tokyo.ac.jp. 11 Center for Supercentenarian Medical Research, Shinjuku-ku, Tokyo 160-8582, Japan. yasumich@keio.jp. 12 Department of Viroscience, Erasmus Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. r.fouchier@erasmusmc.nl. 13 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. yamayo@ims.u-tokyo.ac.jp. 14 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. yoshihiro.kawaoka@wisc.edu. 15 Department of Special Pathogens, International Research Center for Infectious Diseases, Institute Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. yoshihiro.kawaoka@wisc.edu. 16 Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA. yoshihiro.kawaoka@wisc.edu.

[h=3]Abstract[/h] Human influenza A(H2N2) viruses emerged in 1957 and were replaced by A(H3N2) viruses in 1968. The antigenicity of human H2N2 viruses has been tested by using ferret antisera or mouse and human monoclonal antibodies. Here, we examined the antigenicity of human H2N2 viruses by using human plasma samples obtained from 50 aged individuals who were born between 1928 and 1933 and from 33 younger adult individuals who were born after 1962. The aged individuals possessed higher neutralization titers against H2N2 viruses isolated in 1957 and 1963 than those against H2N2 viruses isolated in 1968, whereas the younger adults who were born between 1962 and 1968 possessed higher neutralization titers against H2N2 viruses isolated in 1963 than those against other H2N2 viruses. Antigenic cartography revealed the antigenic changes that occurred in human H2N2 viruses during circulation in humans for 11 years, as detected by ferret antisera. These results show that even though aged individuals were likely exposed to more recent H2N2 viruses that are antigenically distinct from the earlier H2N2 viruses, they did not possess high neutralizing antibody titers to the more recent viruses, suggesting immunological imprinting of these individuals with the first H2N2 viruses they encountered and that this immunological imprinting lasts for over 50 years.


[h=4]KEYWORDS:[/h] H2N2; aged individuals; antigenic change; antigenic drift; influenza A virus

PMID: 31652870 DOI: 10.3390/v11110978
 
Back
Top Bottom